Middle East And Africa Blood Glucose Monitoring Market Size (2024 - 2029)

Middle East and Africa Blood Glucose Monitoring Market Analysis

The Middle East And Africa Blood Glucose Monitoring Market size is estimated at USD 4.34 million in 2024, and is expected to reach USD 6.51 million by 2029, growing at a CAGR of greater than 8.55% during the forecast period (2024-2029).

Diabetes and COVID-19 have a significant influence on public health not just overseas but also in the Middle East and Africa. In COVID-19 patients, diabetes has been reported to increase the incidence of both fatal infections and serious infections. Because diabetes is one of the primary health issues that is incredibly prevalent in the Middle East and African countries, the present research focused on understanding the epidemiology of COVID-19 in people with diabetes and the initiatives put in place by the governments to decrease its impact.

There is an increasing incidence of lifestyle diseases, such as diabetes, in developing countries that are increasing the demand for blood glucose monitoring devices. The increased awareness about healthcare facilities and preventive care is also supporting the growth of the market. The number of patients relying on self-monitoring blood glucose (SMBG) has increased. Owing to the high-cost constraints associated with continuous glucose monitoring (CGM), self-monitoring by glucometer is more acceptable in the Middle-East and Africa region. These devices help in the early detection of hypo and hyperglycemia conditions, which tend to drive the market for glucose monitoring.

Middle East and Africa Blood Glucose Monitoring Industry Segmentation

Using a glucose meter to measure the amount of glucose in the blood (glycemia) is known as blood glucose monitoring. A blood glucose test is normally conducted by piercing the skin (often via fingerstick) to extract blood, then putting the blood on a chemically active disposable "test strip," which is particularly significant in the treatment of diabetes. Continuous glucose monitoring (CGM) is the primary alternative. While different manufacturers employ various technologies, the majority of devices monitor an electrical characteristic and utilize this information to calculate the blood glucose level. The Middle East and Africa blood glucose monitoring market is segmented by product type (self-monitoring blood glucose, continuous glucose monitoring), End User (Hospital/clinics and Home/Personal), and geography (Saudi Arabia, Egypt, Oman, South Africa, and the rest of the Middle East and Africa). The report offers the value (in USD) and volume (in units) for the above segments. We will provide a segment-wise breakdown (value and volume) for all the countries covered under the Table of Contents.